These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2876449)

  • 21. Striatal dopamine D2 receptors in tardive dyskinesia: PET study.
    Blin J; Baron JC; Cambon H; Bonnet AM; Dubois B; Loc'h C; Mazière B; Agid Y
    J Neurol Neurosurg Psychiatry; 1989 Nov; 52(11):1248-52. PubMed ID: 2574230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expected incidence of tardive dyskinesia associated with atypical antipsychotics.
    Glazer WM
    J Clin Psychiatry; 2000; 61 Suppl 4():21-6. PubMed ID: 10739327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tardive dyskinesia: clinical, biological, and pharmacological perspectives.
    Berger PA; Rexroth K
    Schizophr Bull; 1980; 6(1):102-16. PubMed ID: 6102788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intermittent neuroleptic therapy and tardive dyskinesia: a literature review.
    Goldman MB; Luchins DJ
    Hosp Community Psychiatry; 1984 Dec; 35(12):1215-9. PubMed ID: 6150891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and epidemiologic aspects of tardive dyskinesia.
    Baldessarini RJ
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):8-13. PubMed ID: 2858483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The present status of tardive dyskinesia and akathisia in the treatment of schizophrenia.
    Barnes TR
    Psychiatr Dev; 1987; 5(4):301-19. PubMed ID: 2895467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BAEP screening for the prediction of tardive dyskinesia in schizophrenia.
    Coger RW; Bartzokis G; Serafetinides EA
    Psychiatry Res; 1989 Apr; 28(1):117-8. PubMed ID: 2568004
    [No Abstract]   [Full Text] [Related]  

  • 28. Is there a presynaptic tardive dyskinesia?
    Bowers MB; Glazer WM
    J Clin Psychopharmacol; 1987 Feb; 7(1):57-9. PubMed ID: 2880877
    [No Abstract]   [Full Text] [Related]  

  • 29. The current status of tardive dyskinesia.
    Sachdev PS
    Aust N Z J Psychiatry; 2000 Jun; 34(3):355-69. PubMed ID: 10881961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aripiprazole-induced tardive dyskinesia: the role of tamoxifen.
    Evcimen YA; Evcimen H; Holland J
    Am J Psychiatry; 2007 Sep; 164(9):1436-7. PubMed ID: 17728431
    [No Abstract]   [Full Text] [Related]  

  • 31. [Dose reduction of conventional antipsychotics: does it reduce tardive dyskinesia?].
    van Berkel M; Bogers JP; Bouvy PF
    Tijdschr Psychiatr; 2007; 49(1):37-41. PubMed ID: 17225204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Current status of our knowledge of the neurotropic side effects of neuroleptic drugs].
    Sabbatini F; Pinessi L; Gentile S; De Mattei M; Portaleone P
    Minerva Psichiatr; 1983; 24(4):145-53. PubMed ID: 6145083
    [No Abstract]   [Full Text] [Related]  

  • 33. Phosphodiesterase 4B genetic variants are not associated with antipsychotic-induced tardive dyskinesia.
    Souza RP; Remington G; Meltzer HY; Lieberman JA; Kennedy JL; Wong AH
    Int Clin Psychopharmacol; 2010 Sep; 25(5):264-9. PubMed ID: 20436352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prevention of tardive dyskinesia caused by neuroleptic therapy].
    Perényi A
    Orv Hetil; 1981 Jul; 122(27):1627-30. PubMed ID: 6117046
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical effectiveness of the Kampo medicine kamishoyosan for adjunctive treatment of tardive dyskinesia in patients with schizophrenia: a 16-week open trial.
    Lee JG; Shin BS; Lee YC; Park SW; Kim YH
    Psychiatry Clin Neurosci; 2007 Oct; 61(5):509-14. PubMed ID: 17875029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroleptic plasma levels and tardive dyskinesia: a possible link?
    Nasrallah HA
    Schizophr Bull; 1980; 6(1):4-7. PubMed ID: 6102792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of neuroleptic discontinuation on psychopathology, involuntary movements, and biochemical measures in patients with persistent tardive dyskinesia.
    Glazer WM; Bowers MB; Charney DS; Heninger GR
    Biol Psychiatry; 1989 Jul; 26(3):224-33. PubMed ID: 2568132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcium blockers in tardive dyskinesia.
    Doggett NS; Mercurio GG
    Am J Psychiatry; 1989 Jan; 146(1):121-2. PubMed ID: 2563208
    [No Abstract]   [Full Text] [Related]  

  • 39. Improvement in tardive dyskinesia after muscimol therapy.
    Tamminga CA; Crayton JW; Chase TN
    Arch Gen Psychiatry; 1979 May; 36(5):595-8. PubMed ID: 35117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association study indicates a protective role of phosphatidylinositol-4-phosphate-5-kinase against tardive dyskinesia.
    Fedorenko OY; Loonen AJ; Lang F; Toshchakova VA; Boyarko EG; Semke AV; Bokhan NA; Govorin NV; Aftanas LI; Ivanova SA
    Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25548108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.